ST中珠(600568) - 2021 Q1 - 季度财报

Financial Performance - Operating revenue decreased by 29.61% to CNY 93,388,534.23 compared to the same period last year[6] - Net profit attributable to shareholders was CNY -24,761,796.46, showing a slight improvement of 0.02% year-on-year[6] - The net profit excluding non-recurring gains and losses was CNY -26,156,995.74, a decrease of 7.34% year-on-year[6] - The company reported a net loss of ¥1,315,306,261.02 in retained earnings, indicating ongoing financial challenges[32] - Total operating revenue for Q1 2021 was ¥93,388,534.23, a decrease of 29.6% compared to ¥132,678,078.74 in Q1 2020[37] - Net loss for Q1 2021 was ¥26,438,456.07, compared to a net loss of ¥23,615,659.34 in Q1 2020, representing an increase in loss of 12.0%[38] - The company’s total profit for Q1 2021 was -¥25,135,146.66, compared to -¥20,766,860.18 in Q1 2020, indicating a worsening of 21.5%[37] Assets and Liabilities - Total assets increased by 5.19% to CNY 4,760,205,084.14 compared to the end of the previous year[6] - Total current assets amounted to CNY 2,099,488,356.19 as of December 31, 2020, with a slight adjustment of -CNY 444,651.30[46] - Non-current assets increased to CNY 2,425,846,552.37 as of January 1, 2021, reflecting an adjustment of +CNY 291,374,278.79 due to the new leasing standards[47] - Total liabilities rose to ¥806,858,360.12, compared to ¥545,442,455.38, indicating an increase of around 47.7%[32] - Current liabilities decreased to ¥435,190,201.84 from ¥459,196,500.72, a reduction of approximately 5.6%[31] - Shareholders' equity totaled ¥3,953,346,724.02, slightly down from ¥3,979,892,453.18, a decrease of about 0.7%[32] Cash Flow - Net cash flow from operating activities was CNY -533,750.57, a decrease of 100.89% compared to the previous year[6] - In Q1 2021, the company's operating cash inflow was CNY 149,053,240.84, a decrease of 34.9% from CNY 229,118,110.98 in Q1 2020[42] - The company reported a total cash and cash equivalents balance of CNY 569,023,816.35 at the end of Q1 2021, down from CNY 694,509,394.33 at the beginning of the quarter[43] - Investment activities resulted in a net cash outflow of -CNY 123,595,874.39, significantly higher than -CNY 34,078,877.67 in Q1 2020[43] - The company’s financing activities generated a net cash outflow of -CNY 1,355,953.02, compared to a net inflow of CNY 54,182,839.54 in the previous year[43] Shareholder Information - The number of shareholders at the end of the reporting period was 34,282[10] - The largest shareholder, Shenzhen Yiti Investment Holding Group Co., Ltd., holds 12.66% of shares, totaling 252,324,862 shares[11] - The second-largest shareholder, Zhuhai Zhongzhu Group Co., Ltd., holds 12.19% of shares, totaling 242,992,811 shares[11] - As of now, the company has recovered approximately ¥10,010 million from a total of ¥19,546.71 million owed by a subsidiary, with about ¥9,502.04 million still outstanding[20] Legal and Regulatory Issues - The company is involved in ongoing litigation regarding outstanding debts totaling ¥47,296.81 million from the sale of various subsidiaries, with efforts to recover these funds through legal channels[18] - The company has been subject to an investigation by the China Securities Regulatory Commission for potential violations of information disclosure laws, which may pose risks to its stock listing status[17] - The company has filed a lawsuit against Yiti Group and its affiliates for unfulfilled performance commitments, with the court ruling in favor of the company[26] - Zhongzhu Medical has submitted a debt claim of 28,267,930 RMB in the bankruptcy proceedings of Yiti Group, with the claim status still pending confirmation[27] Operational Metrics - The company reported a government subsidy of CNY 2,002,128.02 related to normal business operations[8] - The company reported a 30.19% decrease in operating costs to ¥72,472,569.42 in Q1 2021 from ¥103,814,433.57 in Q1 2020, mainly due to reduced costs in the real estate sector[14] - Research and development expenses increased to ¥8,405,433.57 in Q1 2021, up 25.7% from ¥6,685,555.10 in Q1 2020[37] - Other income for Q1 2021 was ¥2,002,128.02, a decrease of 40.0% from ¥3,333,547.22 in Q1 2020[37]